Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia A

Condition:   Hemophilia A Intervention:   Biological: valoctocogene roxaparvovec Sponsor:   BioMarin Pharmaceutical Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials